Amedisys (AMED) Stock Price
Amedisys Price
Revenue has compounded at 10.0% per year over the past 19 years to 2.35 B USD. Earnings per share have declined at 0.3% per year over the last 19 years. Amedisys's net margin stands at 1.8%, down from 8.9% several years earlier. Analysts set a median price target of 103.02 USD, implying 2.0% above the current price. Of 17 analysts, 1 rate the stock a buy — an overall Hold consensus.
Amedisys stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Amedisys business model & stock analysis
Frequently asked questions about Amedisys
Amedisys Inc is a leading provider of home healthcare services in the United States. The company's business model revolves around offering personalized medical care in the comfort of patients' own homes. Amedisys provides a wide range of healthcare services, including skilled nursing, physical therapy, and hospice care, with a focus on delivering high-quality and cost-effective care. Through its team of dedicated professionals, Amedisys strives to improve patients' health outcomes and enhance their overall quality of life. With a patient-centered approach, Amedisys aims to be a trusted partner in the healthcare industry, delivering exceptional care tailored to each individual's needs.
Amedisys Inc is primarily active in the healthcare industry, specifically in the home health and hospice sectors. With a vast network of skilled nurses, therapists, and medical professionals, Amedisys provides comprehensive and compassionate care to patients in the comfort of their own homes. This industry-leading company offers a wide range of quality services, including medical and personal care, rehabilitation, and end-of-life care. Amedisys Inc's steadfast commitment to the healthcare industry has solidified its position as a trusted provider of exceptional care and support to patients and their families.
The main competitors of Amedisys Inc in the market include LHC Group Inc, Encompass Health Corporation, and Brookdale Senior Living Inc. These companies also operate in the home healthcare and hospice services industry, providing similar services and competing for market share. Amedisys Inc faces strong competition from these industry players in delivering quality healthcare services to patients in their homes.
Amedisys Inc. is a leading healthcare services company with a rich history and background. Established in 1982, Amedisys has been dedicated to providing high-quality personalized care to patients across the United States. The company specializes in providing home healthcare, hospice, and personal care services, ensuring patients can receive medical attention and assistance in the comfort of their own homes. Amedisys has grown exponentially over the years, currently serving over 420,000 patients annually. With a team of skilled healthcare professionals, technological advancements, and a commitment to compassionate care, Amedisys Inc. continues to play a pivotal role in the healthcare industry.
Amedisys Inc, a leading healthcare at home provider, has achieved significant milestones since its inception. The company's commitment to delivering exceptional patient care and innovative solutions has propelled its growth. Amedisys Inc reached a major milestone when it became the first home healthcare company listed on the NASDAQ in 1987. The company's continuous expansion and acquisitions have strengthened its market presence. Amedisys Inc's strategic initiatives, such as its partnership with Contessa, demonstrate its dedication to advancing care delivery models. With a strong focus on quality outcomes and patient satisfaction, Amedisys Inc has consistently achieved industry recognition and awards, solidifying its position as a reputable leader in the healthcare sector.
Amedisys Inc is primarily present in the United States. As a leading provider of home healthcare and hospice services, Amedisys operates across various states and regions within the country. With its headquarters located in Baton Rouge, Louisiana, the company has a widespread presence throughout the nation. Amedisys Inc has established itself as a trusted name in the healthcare industry, offering quality in-home care to patients in numerous communities across the United States.
Amedisys Inc represents values of integrity, compassion, and excellence in the healthcare industry. With a strong corporate philosophy focused on providing high-quality patient care, Amedisys aims to enhance the overall well-being and health outcomes of individuals. The company is committed to delivering personalized, patient-centered services through its team of dedicated professionals. Amedisys prioritizes innovation, teamwork, and an unwavering commitment to professionalism and ethical practices. By consistently upholding these values, Amedisys Inc ensures that patients receive the best possible care and support to improve their overall quality of life.
Analysts currently set an average price target of 102.87 USD for the Amedisys stock (median: 103.02 USD), implying +1.9 % versus the latest price. The consensus is based on 17 analyst ratings.
17 analysts currently rate the Amedisys stock: 1 recommend buying, 12 holding and 4 selling. For 2026, analysts expect Amedisys to generate revenue of 2.58 B USD and earnings per share of 5.22 USD.
Converted at the current exchange rate, the Amedisys share trades at 90.49 EUR (100.99 USD).
The Amedisys share (AMED) is listed on 4 stock exchanges, including: NASDAQ (AMED), SIX (Zürich) (ADY.SW), Frankfurt (ADY.F), München (ADY.MU).
Amedisys Inc. is a leading US provider of innovative home healthcare services. The company was founded in 1982 and went public for the first time in 2005. Since then, Amedisys has consistently grown and is now one of the largest providers of home healthcare in the USA. The company operates in three core areas: Home Health, Hospice, and Personal Care. By offering these three areas, Amedisys aims to provide the best possible patient experience and valuable support for patients and their families. The following sections provide more details on these areas. Home Health: Amedisys offers a wide range of home health services for patients who need care at home. These services include nursing, therapeutic treatments, medical devices and aids that can be used to support patients at home, as well as education and prevention programs. The Home Health area primarily targets older patients with chronic illnesses. Hospice: In the hospice program, Amedisys provides nursing support for patients nearing the end of their lives. The program is designed for patients who are seriously ill and in the final stage of their lives. Amedisys offers support through pain management, emotional and spiritual support, as well as support in caregiving by household or nursing staff. The hospice program aims to help patients end their lives in peace and dignity. Personal Care: In the Personal Care area, Amedisys provides home support and daily care for patients who have difficulty caring for themselves. The program is designed for patients who need support due to aging, illness, or injury. Amedisys caregivers assist patients with everyday tasks such as bathing, dressing, and medication management. Additionally, they provide household support and assistance with other activities to enable independent living. Products: Amedisys offers various medical devices and aids that can be used by patients at home. This includes items such as blood pressure monitors, oxygen devices, incontinence materials, and other medical supplies. In addition, Amedisys also offers education and prevention programs to help patients better understand and improve their health and well-being. In summary, Amedisys aims to provide high-quality, innovative, and effective home healthcare services. With the three core areas of Home Health, Hospice, and Personal Care, Amedisys aims to support patients of all ages with different needs and help them improve their health and well-being.
The expected revenue of Amedisys is 2.58 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Amedisys is 170.76 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Amedisys is currently 19.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Amedisys stock.
The price-to-sales ratio (P/S) of Amedisys is currently 1.28. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Amedisys stock.
The Eulerpool Quality Score for Amedisys is 3/10.
The ISIN of Amedisys is US0234361089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Amedisys is 915582. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Amedisys is AMED. The ticker symbol is used to trade Amedisys shares on the stock exchange.
Amedisys stock
Amedisys Peer Group
Amedisys Ticker
Amedisys FIGI
All fundamentals and in-depth analysis of Amedisys
Our stock analysis for Amedisys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.